WHO ICTRP trial

The efficacy and safety of 'CGGEL' for bleeding during endoscopic papillectomy…

KCT0005607 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0005607
Public title The efficacy and safety of 'CGGEL' for bleeding during endoscopic papillectomy or endoscopic sphincterotom: randomized, controlled trial
Scientific title Evaluation of the efficacy (1st hemostasis) and safety of CGGEL and Epinephrine spray on gastrointestinal bleeding patient who underwent Endoscopic Sphincterotomy (EST) or Endoscopic papillectomy to treat Pancreatobiliary Disease: A multi-center, Subject-Blind, Randomized, Active Comparator…
Primary sponsor Seoul National University Hospital
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Not applicable
Countries Korea, Republic of
Conditions Diseases of the digestive system
Interventions Medical Device : In patient with bleeding during EST or endoscopic papillary, CGGEL, a powdered hemostatic agent, is sprayed onto the bleeding site in the experimental group. And a diluted epinephrine solution (1:10,000) is sprayed in the…
Registration date Nov 18, 2020
Target size 84
Registry page cris.nih.go.kr

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations